Back
BioXcel Therapeutics Stock Price Chart
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
21
BTAI
BioXcel Therapeutics
Last Price:
$1.53
Seasonality Move:
-13.11%
7 Day Trial
ALL ACCESS PASS
$
7
Former Zillow execs target $1.3T market
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BTAI is experiencing selling pressure, which indicates risk of future bearish movement.
BioXcel Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.67 | Sell |
| 20-day SMA: | 1.76 | Sell |
| 50-day SMA: | 2.07 | Sell |
| 200-day SMA: | 6.84 | Sell |
| 8-day EMA: | 1.64 | Sell |
| 20-day EMA: | 1.75 | Sell |
| 50-day EMA: | 2.25 | Sell |
| 200-day EMA: | 12.36 | Sell |
BioXcel Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 37.57 | Sell |
| Chaikin Money Flow: | -42614 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.59 - 1.87) | Sell |
| Bollinger Bands (100): | (1.56 - 5.32) | Sell |
BioXcel Therapeutics Technical Analysis
| Apr 28 | Apr 29 | Apr 30 | May 1 | May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | May | |||||||||
| 28 | 29 | 30 | 01 | 02 | 05 | 06 | 07 | 08 | 09 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for BioXcel Therapeutics Stock
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.53 while BTAI 8-day simple moving average is 1.67, which is a Sell signal.
-
The stock price of BTAI is 1.53 while BioXcel Therapeutics 20-day SMA is 1.76, which makes it a Sell.
-
BioXcel Therapeutics 50-day simple moving average is 2.07 while BTAI share price is 1.53, making it a Sell technically.
-
BTAI stock price is 1.53 and BioXcel Therapeutics 200-day simple moving average is 6.84, creating a Sell signal.
BTAI Technical Analysis vs Fundamental Analysis
Sell
21
BioXcel Therapeutics (BTAI)
is a Sell
Is BioXcel Therapeutics a Buy or a Sell?
-
BioXcel Therapeutics stock is rated a SellThe current BioXcel Therapeutics [BTAI] share price is $1.53. The Score for BTAI is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
BioXcel Therapeutics Stock Info
Market Cap:
8.4M
Price in USD:
1.53
Share Volume:
72.9K
BioXcel Therapeutics 52-Week Range
52-Week High:
37.28
52-Week Low:
1.29
Sell
21
BioXcel Therapeutics (BTAI)
is a Sell
BioXcel Therapeutics Share Price Forecast
-
What is the BioXcel Therapeutics stock price today?The BioXcel Therapeutics stock price is 1.53 USD today.
-
Will BTAI stock go up or go down?BioXcel Therapeutics> share price is forecast to RISE/FALL based on technical indicators
-
Is BioXcel Therapeutics overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, BioXcel Therapeutics is overvalued.
Is BioXcel Therapeutics Stock a Buy?
-
BioXcel Therapeutics share price is 1.53 while BTAI 8-day exponential moving average is 1.64, which is a Sell signal.
-
The stock price of BTAI is 1.53 while BioXcel Therapeutics 20-day EMA is 1.75, which makes it a Sell.
-
BioXcel Therapeutics 50-day exponential moving average is 2.25 while BTAI share price is 1.53, making it a Sell technically.
-
BTAI stock price is 1.53 and BioXcel Therapeutics 200-day simple moving average is 12.36, creating a Sell signal.
Fundamental Analysis of BioXcel Therapeutics
Is BioXcel Therapeutics a good investment?
-
Analysts estimate an earnings increase this quarter of $5.84 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.06 per share, and an increase next year of $7.39 per share.
Technical Analysis of BioXcel Therapeutics
Should I short BioXcel Therapeutics stock?
-
BTAI Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting BioXcel Therapeutics is a Sell
-
BioXcel Therapeutics Relative Strength Index (RSI) is 37.57, which suggest BioXcel Therapeutics is oversold
-
The Bollinger Bands (25) for BioXcel Therapeutics is (1.59 - 1.87), which suggest BioXcel Therapeutics is a Sell
-
The Bollinger Bands (100) for BioXcel Therapeutics is (1.56 - 5.32), which suggest BioXcel Therapeutics is a Sell
* BioXcel Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.